Research & Policy

Corporate stories about Research & Policy across 3BL's network.

Latest in Research & Policy

The Impact of World Changing Technologies
Technology that makes a positive impact in our global communities, when and where it's needed most. That's why we strive to innovate in all of our businesses.
Reopening: It's All About the Execution
High expectations around reopening may already be substantially priced into markets, pointing to new risks around how the reopening actually plays out.
Alkermes Presents New Data From Psychiatry Portfolio at Virtual 2021 Congress of the Schizophrenia International Research Society
Alkermes plc (Nasdaq: ALKS) recently announced the presentation of new research from its psychiatry portfolio at the 2021 Congress of the Schizophrenia International Research Society (SIRS), taking place virtually April 17-21, 2021.
Healthcare Plastics Recycling Council Publishes White Paper on Advanced Recycling Technologies
The Healthcare Plastics Recycling Council (HPRC) has published a white paper, Advanced Recycling of Healthcare Plastics: An Opportunity for Circularity, to explore advanced recycling technologies.
With Lenovo, TechsoMed Is Spurring a Revolution in Cancer Treatment
The partnership between TechsoMed and Lenovo is enabling physicians to target cancer with never before seen precision.
Alkermes Shares Immuno Oncology Clinical Trial Research
We are pleased to share clinical trial data on our investigational #immunooncology therapy and are excited to be a part of the 17th EADO Congress and 2021 World Mobile Congress Interactive Virtual Meeting.
An Analysis on Bacterial Growth on Vinyl and Polished Concrete
Bacteria growth in flooring of hospitals, grocery stores, warehouses, etc. is extremely dangerous for human health. A more permeable surface is a result of a porous material that is more susceptible to this harmful bacterial growth.
Abbott's BinaxNOW™ Rapid Antigen Self Test Receives FDA Emergency Use Authorization for Asymptomatic, Over-the-Counter, Non-Prescription, Multi-Test Use
Abbott (NYSE: ABT) announced today it has received U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA) for over-the-counter, non-prescription, asymptomatic use of its BinaxNOW™ COVID-19 Ag Self Test for detection of COVID-19 infection.

Latest Campaigns

Health and Safety by Antea Group

Antea Group's health and safety consultants understand what it takes to help make a positive impact on safety culture. Read blogs, insights, and more...

Wesco Cares

Life-changing events can happen to any of us, often when we least expect them. Employees in need can turn to the Wesco Cares. Its mission is to be an...

People

As a family-owned business, Bacardi values the importance of creating a warm and welcoming workplace. We do so by fostering an environment where...

Collaboration and Partnership

Cascale shares updates on its strategic partnerships with industry stakeholders geared toward shifting the industry into one that gives back more than...

Sustainable Products and Innovation

Ongoing research into innovative solutions enables CNH’s brands to manufacture products that respect the environment while satisfying customers’...

Education

Our technology is playing a vital role in helping educators inspire students and boost achievement. Learn more here.

Prescription for a Better World

Prescription for a Better World defines CVS Health's CSR strategy and is aligned to support the company’s purpose of helping people on their path to...